Last reviewed · How we verify

NCT05578911: AutoMed-Int

Medical Follow-up and Self-medication Among Medical Students

Completed Last updated 14 November 2022
What this trial tests

trial testing "medical students" group in Medical Student in 264 participants. Completed in 7 November 2022.

Timeline
5 October 2022
Primary endpoint
7 November 2022
7 November 2022

Quick facts

Lead sponsorUniversité de Reims Champagne-Ardenne
StatusCompleted
Study typeOBSERVATIONAL
Enrollment264
Start date5 October 2022
Primary completion7 November 2022
Estimated completion7 November 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Université de Reims Champagne-Ardenne

Who can join

18 and older, any sex, with Medical Student. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

As health actors, medical students educate patients to have regular medical follow-up and give them justified medical prescriptions. Regarding their own health, medical students do not seem to apply these same principles. The medical follow-up of medical students seems insufficient, which can be explained by the lack of medical follow-up by occupational medicine, a consequent work time, but also the fear of judgment by colleagues Moreover, medical student have an easy access to all types of prescriptions and therefore the ease of self-prescription and self-medication. Medical students may also overestimate their medical knowledge and may not be objective about their symptomatology.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Medical Student

Currently open trials in the same condition.

Other Université de Reims Champagne-Ardenne trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05578911.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing